Abclone announced on April 7 that the next-generation antibody-drug conjugate (ADC) technology, which it licensed from the ...

👉 Learn how to divide rational expressions having square root binomials. To divide a rational expression having a binomial denominator with a square root radical in one of the terms of the ...

Mo-Rez reduced or eliminated tumours in over 60% of patients and is expected to be a blockbuster drug ...

GSK ( GSK) is preparing a high-stakes push into oncology, lining up five late-stage trials at once for a promising cancer ...

Most people accept that with ageing comes the inevitable decline of our brains. But now, fascinating new research is ...

Zongertinib in phase I trial showed sustained efficacy in aggressive disease ...

A Washington Post reporter’s doctor in Seoul had a question — how to translate “chicken out,” as in “Trump always chickens ...

Christoph has played a pivotal role in shaping the Company's strategic transformation since his appointment as Chief Business Officer in January 2025 C ompany Founder Jacques Lemmens, PhD, remains as ...

After entering 2026 hungry for deals, Gilead Sciences has wasted no time eating its fill. | After entering 2026 hungry for ...

EQT Life Sciences is pleased to announce that the LSP 7 fund ("EQT Life Sciences") has exited its minority stake in Tubulis (the "Company"), a Germany-based, clinical-stage biotechnology company ...

Intensity Therapeutics, Inc., (Nasdaq: INTS) ("Intensity" or the "Company"), a late-stage clinical biotechnology company focused on the discovery and development of proprietary cancer therapies using ...

A highway sign indicating the exit for Cesar E. Chavez Boulevard hangs over I-35 in San Antonio. Despite a city survey ...